The growth suppressor p27 Kip1 protects against diet‐induced atherosclerosis
- 24 July 2001
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 15 (11) , 1989-1995
- https://doi.org/10.1096/fj.01-0130com
Abstract
The molecular basis of atherosclerosis is associated with excessive proliferation of vascular cells. Previous studies have suggested an inverse correlation between the expression of the growth suppressor p27Kip1 (p27) and cellular proliferation within human atherosclerotic tissue. However, no causal link between diminished p27 expression and atherogenesis has been established. We investigated the effect of p27 inactivation on diet-induced atherogenesis. We find that p27-deficient mice challenged with a high-fat diet for 1 month remain normocholesterolemic and have essentially no visible atheromas. However, when generated in an apolipoprotein E-null genetic background that leads to severe hypercholesterolemia in response to the atherogenic diet, deletion of p27 enhances arterial cell proliferation (∼fourfold) and accelerates atherogenesis (∼sixfold) compared with apolipoprotein E-deficient mice with an intact p27 gene. Analysis of apolipoprotein E-null mice bearing only one p27 allele inactivated reveals that a moderate decrease in p27 protein expression in the setting of hypercholesterolemia is sufficient to predispose to atherogenesis. Thus, our study establishes a molecular link between decreased p27 protein expression and atherogenesis in hypercholesterolemic animals.—Díez-Juan, A., Andrés, V. The growth suppressor p27Kip1 protects against diet-induced atherosclerosis.Keywords
This publication has 40 references indexed in Scilit:
- Differential Regulation of P27Kip1 Expression by Mitogenic and Hypertrophic FactorsThe Journal of cell biology, 2000
- A novel role for the cyclin-dependent kinase inhibitor p27Kip1 in angiotensin II–stimulated vascular smooth muscle cell hypertrophyJournal of Clinical Investigation, 1999
- Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populationsThe Lancet, 1999
- Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation.Journal of Clinical Investigation, 1998
- Association between Prior Cytomegalovirus Infection and the Risk of Restenosis after Coronary AtherectomyNew England Journal of Medicine, 1996
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Journal of Clinical Investigation, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsPublished by Elsevier ,1992
- Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissuesCell Proliferation, 1989